Keeson: Its subsidiary, Mai Dong Shu Kang, has launched the first personalized digital therapy for sleep in China

Keeson is expanding its digital sleep industry chain ecosystem through fund-controlled investments, establishing MaiDong ShuKang, and successfully developing multiple sleep service products including digital therapies, digital medications, and brain-computer interfaces, winning Class II medical device registration certificates in various fields. Currently, MaiDong ShuKang has launched the country's first personalized digital therapy product for specific populations—XBT-I Short-term Insomnia Digital Therapy Comprehensive Management System, which breaks through with "brain-computer interface + AI large model" technology, aligning with the national strategic direction to promote innovation and development in the brain-computer interface industry